Alendronate
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | <!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | ||
| - | == ''' | + | == '''Alendronate (Fosamax®)''' == |
| - | + | ||
| + | ---- | ||
| + | |||
| + | Alendronate is a bisphosphonate used to treat and prevent osteoporosis in postmenopausal women and in men.<ref>http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0000018/</ref> | ||
== History == | == History == | ||
| Line 21: | Line 24: | ||
<scene name='Sandbox_59/Active_site_ligand_space_fill/2'>space fill active site with bound ligand</scene> | <scene name='Sandbox_59/Active_site_ligand_space_fill/2'>space fill active site with bound ligand</scene> | ||
| - | <scene name='Sandbox_59/Fpps_bound_phosphate/ | + | <scene name='Sandbox_59/Fpps_bound_phosphate/2'>FPPS bound phosphate</scene> |
| - | <scene name='Sandbox_59/ | + | <scene name='Sandbox_59/Fpps_hydrophobic/1'>hydrphobic FPPS</scene> |
<scene name='Sandbox_59/Fpps/2'>FPPS</scene> | <scene name='Sandbox_59/Fpps/2'>FPPS</scene> | ||
| + | |||
<Structure load='2f92' size='500' frame='true' align='right' caption='FPPS Asymmetric unit' scene='Insert optional scene name here' /> | <Structure load='2f92' size='500' frame='true' align='right' caption='FPPS Asymmetric unit' scene='Insert optional scene name here' /> | ||
== Side affects of Drug == | == Side affects of Drug == | ||
| + | |||
| + | |||
| + | |||
| + | |||
| + | |||
| + | |||
| + | |||
| + | |||
| + | |||
| + | <references/> | ||
Revision as of 04:05, 11 March 2011
| Please do NOT make changes to this Sandbox. Sandboxes 30-60 are reserved for use by Biochemistry 410 & 412 at Messiah College taught by Dr. Hannah Tims during Fall 2012 and Spring 2013. |
Contents |
Alendronate (Fosamax®)
Alendronate is a bisphosphonate used to treat and prevent osteoporosis in postmenopausal women and in men.[1]
History
Structure
Target Protein
|
